BIOMERIEUX SA
Main Filters
BIOMERIEUX SA
BIOMERIEUX SA | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
1.0 | 0 | - | ||
chromID® MRSA agar | 0 | - | ||
chromID™ MRSA /SAID | 0 | - | ||
chromID™ VRE Agar | 0 | - | ||
Etest® AMOXI/CLAV 2/1 | 0 | - | ||
Etest® AMPICILLIN | 0 | - | ||
Etest® AZTREONAM | 0 | - | ||
Etest® CEFTAZIDIME/AVIBACTAM | 0 | - | ||
Etest® CEFTOLOZANE/TAZO | 0 | - | ||
Etest® CEFUROXIME | 0 | - | ||
Etest® CHLORAMPHENICOL | 0 | - | ||
Etest® CIPROFLOXACIN | 0 | - | ||
Etest® CLINDAMYCIN | 0 | - | ||
Etest® DAPTOMYCIN | 0 | - | ||
Etest® DORIPENEM | 0 | - | ||
Etest® ERTAPENEM | 0 | - | ||
Etest® ERYTHROMYCIN | 0 | - | ||
Etest® FLUCONAZOLE | 0 | - | ||
Etest® FLUCYTOSINE | 0 | - | ||
Etest® GATIFLOXACIN | 0 | - | ||
Etest® GEMIFLOXACIN | 0 | - | ||
Etest® GENTAMICIN | 0 | - | ||
Etest® IMIPENEM | 0 | - | ||
Etest® ITRACONAZOLE | 0 | - | ||
Etest® LEVOFLOXACIN | 0 | - | ||
Etest® LINEZOLID | 0 | - | ||
Etest® MEROPENEM | 0 | - | ||
Etest® METRONIDAZOLE | 0 | - | ||
Etest® MINOCYCLINE | 0 | - | ||
Etest® MOXIFLOXACIN | 0 | - | ||
Etest® OFLOXACIN | 0 | - | ||
Etest® OXACILLIN | 0 | - | ||
Etest® PIP/TAZO/CON-4 | 0 | - | ||
Etest® PIPERACILLIN | 0 | - | ||
ETEST® Piperacillin/Tazobactam | 0 | - | ||
Etest® QUINUPRI/DALFO | 0 | - | ||
Etest® RIFAMPICIN | 0 | - | ||
Etest® TELAVANCIN | 0 | - | ||
Etest® TETRACYCLINE | 0 | - | ||
Etest® TIC/CLAV-CON2 | 0 | - | ||
Etest® TIGECYCLINE | 0 | - | ||
Etest® TOBRAMYCIN | 0 | - | ||
Etest® TRIM/SULFA 1/19 | 0 | - | ||
Etest® TRIMETHOPRIM | 0 | - | ||
Etest® VANCOMYCIN | 0 | - | ||
Etest® VORICONAZOLE | 0 | - | ||
VIDAS® Serum Free | 0 | - | ||
VITEK® MS CHCA | 0 | - | ||
VITEK® MS-DS | 0 | - | ||
VITEK® MS-FA | 0 | - |
318 Results
Results Per Page
- 50
- 100
- 250
Catalog #
Available
Starting At
Name
Company Name
Description
0
-
ETEST® Piperacillin/Tazobactam
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
THxID™ BRAF
BIOMERIEUX SA
Software used in combination with the THxIDTM- BRAF assay(used to identify patients with melanoma whose tumors harbor the BRAF V600E/K mutations)
0
-
VITEK® MS CHCA
BIOMERIEUX SA
The VITEK MS-CHCA matrix is used with the VITEK® MS System to enable identification of microorganisms. The matrix absorbs energy from the VITEK MS laser and transfers it to the microorganisms
0
-
Etest® AZTREONAM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
VITEK® MS-FA
BIOMERIEUX SA
VITEK ® MS - FA is used to pretreat yeasts to facilitate their identification according to the MALDI - TOF method. It is used exclusively with the VITEK ® MS instrument.
0
-
VITEK® MS-DS
BIOMERIEUX SA
Target slide used for running samples on the VITEK MS containing 48 spots with 3 sections of 16
0
-
CHROMID® VRE Agar
BIOMERIEUX SA
Chromogenic medium for the qualitative detection of Enterococcus faecium and E. faecalis showing acquired vancomycin resistance (VRE) in stool specimens.
0
-
CHROMID® MRSA agar
BIOMERIEUX SA
Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus (MRSA)
0
-
chromID™ MRSA /SAID
BIOMERIEUX SA
Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus and selective isolation of staphylococci and the direct identification of S. aureus.
0
-
VIDAS® Serum Free
BIOMERIEUX SA
The Serum free reagent can be used with VIDAS ® assays for which its use is clearly indicated in the VIDAS assay package insert.
0
-
Etest® AMPICILLIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® AMOXI/CLAV 2/1
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TELAVANCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CEFTOLOZANE/TAZO
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Doripenem (DOR)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® DAPTOMYCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Tigecycline (TGC)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® VORICONAZOLE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® ERTAPENEM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® LINEZOLID
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® GATIFLOXACIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® METRONIDAZOLE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® MOXIFLOXACIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® QUINUPRI/DALFO
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® LEVOFLOXACIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® RIFAMPICIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® ITRACONAZOLE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® VANCOMYCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TRIM/SULFA 1/19
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TRIMETHOPRIM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TIC/CLAV-CON2
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TETRACYCLINE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TOBRAMYCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® PIPERACILLIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® PIP/TAZO/CON-4
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® OXACILLIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® OFLOXACIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® MINOCYCLINE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® MEROPENEM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® IMIPENEM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® GENTAMICIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® FLUCYTOSINE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® FLUCONAZOLE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® ERYTHROMYCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CLINDAMYCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CIPROFLOXACIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CHLORAMPHENICOL
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CEFUROXIME
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CEFTAZIDIME/AVIBACTAM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.